Drug Trial Radar · NCT07946068
Aleniglipron Renal Impairment Study
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
16
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effect of severe RI on IHD on the PK of aleniglipron to establish scientifically guided dosing recommendations in these special patient populations.
Conditions
- Renal Impairment
- Severe Renal Impairment
Interventions
AleniglipronDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma PK parameters for aleniglipron including, but not limited to AUC0-tTime frame: Baseline to Day 3
- Plasma PK parameters for aleniglipron including, but not limited to AUC0-infTime frame: Baseline to Day 3
- Plasma PK parameters for aleniglipron including, but not limited to CmaxTime frame: Baseline to Day 3
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Site
Orlando, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.